Glycated hemoglobin and risk of death in diabetic patients treated with hemodialysis: A meta-analysis

American Journal of Kidney Diseases

Volumn 63, Issue 1, 2014, Pages 84-94

  Hill, Christopher J ^a,b   Maxwell, Alexander P ^a,b   Cardwell, Christopher R ^a   Freedman, Barry I ^c   Tonelli, Marcello ^d   Emoto, Masanori ^e   Inaba, Masaaki ^e   Hayashino, Yasuaki ^f   Fukuhara, Shunichi ^g,h   Okada, Tomonari ⁱ   Drechsler, Christiane ^j   Wanner, Christoph ^j   Casula, Anna ^k   Adler, Amanda I ^l   Lamina, Claudia ^m   Kronenberg, Florian ^m   Streja, Elani ⁿ   Kalantar Zadeh, Kamyar ⁿ   Fogarty, Damian G ^a,b,j  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f TENRI HOSPITAL   (Japan)

^g KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

ⁱ TOKYO MEDICAL UNIVERSITY   (Japan)

^j UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^k SOUTHMEAD HOSPITAL   (United Kingdom)

^l ADDENBROOKE S HOSPITAL   (United Kingdom)

^m INNSBRUCK MEDICAL UNIVERSITY   (Austria)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ARTICLE; DIABETES MELLITUS; DIABETIC PATIENT; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; META ANALYSIS; MORTALITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

DIABETES MELLITUS; HBA1C; HEMODIALYSIS; SURVIVAL;

DIABETIC NEPHROPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MORTALITY; OBSERVATIONAL STUDY AS TOPIC; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84896498578     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.06.020     Document Type: Article

References (60)

1. J. Gilg, C. Castledine, and D. Fogarty UK Renal Registry 14th annual report: chapter 1 UK RRT incidence in 2010: national and centre-specific analyses Nephron Clin Pract 120 2012 C1 C27
2. A.J. Collins, R.N. Foley, and C. Herzog et al. US Renal Data System 2012 annual data report Am J Kidney Dis 61 1 suppl 1 2013 e1 e480
3. H.T. Kuo, M.S. Sampaio, F. Vincenti, and S. Bunnapradist Associations of pretransplant diabetes mellitus, new-onset diabetes after transplant, and acute rejection with transplant outcomes: an analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) Database. Am J Kidney Dis 56 6 2010 1127 1139
4. J.J. Carrero, D.J. de Jager, and M. Verduijn et al. Cardiovascular and noncardiovascular mortality among men and women starting dialysis Clin J Am Soc Nephrol 6 7 2011 1722 1730
5. R. Ravanan, U. Udayaraj, and D. Ansell et al. Variation between centres in access to renal transplantation in UK: longitudinal cohort study BMJ 341 2010 c3451
6. National Kidney Foundation KDOQI clinical practice guideline for diabetes and CKD: 2012 update Am J Kidney Dis 60 5 2012 850 886
7. S. Holt, and D. Goldsmith Renal Association Clinical Practice Guideline: Cardiovascular Disease in CKD 2010 Renal Association Petersfield, United Kingdom
8. D.M. Nathan, D.E. Singer, K. Hurxthal, and J.D. Goodson The clinical information value of the glycosylated hemoglobin assay N Engl J Med 310 6 1984 341 346
9. D.M. Nathan, H. Turgeon, and S. Regan Relationship between glycated hemoglobin levels and mean glucose levels over time Diabetologia 50 11 2007 2239 2244
10. C.L. Rohlfing, H.M. Wiedmeyer, R.R. Little, J.D. England, A. Tennill, and D.E. Goldstein Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial Diabetes Care 25 2 2002 275 278
11. S.G. Coca, F. Ismail-Beigi, N. Haq, H.M. Krumholz, and C.R. Parikh Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus systematic review and meta-analysis Arch Intern Med 172 10 2012 761 769
12. I.H. de Boer, W.J. Sun, and P.A. Cleary et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes N Engl J Med 365 25 2011 2366 2376
13. I.M. Stratton, A.I. Adler, and H.A.W. Neil et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 7258 2000 405 412
14. D.M. Nathan, B. Zinman, and P.A. Cleary et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005) Arch Intern Med 169 14 2009 1307 1316
15. D.M. Nathan, P.A. Cleary, and J.Y. Backlund et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes N Engl J Med 353 25 2005 2643 2653
16. P. Gaede, H. Lund-Andersen, H.H. Parving, and O. Pedersen Effect of a multifactorial intervention on mortality in type 2 diabetes N Engl J Med 358 6 2008 580 591
17. K. Shima, K. Chujo, M. Yamada, M. Komatsu, Y. Noma, and T. Mizuguchi Lower value of glycated hemoglobin relative to glycaemic control in diabetic patients with end-stage renal disease not on hemodialysis Ann Clin Biochem 49 2012 68 74
18. N. Mittman, B. Desiraju, and I. Fazil et al. Serum fructosamine versus glycosylated hemoglobin as an index of glycemic control, hospitalization, and infection in diabetic hemodialysis patients Kidney Int Suppl 117 2010 S41 S45
19. K. Fukuoka, K. Nakao, and H. Morimoto et al. Glycated albumin levels predict long-term survival in diabetic patients undergoing hemodialysis Nephrology 13 4 2008 278 283
20. H. Nagayama, M. Inaba, and R. Okabe et al. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test Biomed Pharmacother 63 3 2009 236 240
21. T.P. Peacock, Z.K. Shihabi, and A.J. Bleyer et al. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis Kidney Int 73 9 2008 1062 1068
22. M. Inaba, S. Okuno, and Y. Kumeda et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection J Am Soc Nephrol 18 3 2007 896 903
23. 1c Clin Chem 51 4 2005 681 683
24. P. Desjardins, A.F. Turgeon, and M.H. Tremblay et al. Hemoglobin levels and transfusions in neurocritically ill patients: a systematic review of comparative studies Crit Care 16 2 2012 R54
25. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 7414 2003 557 560
26. R. Dersimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 3 1986 177 188
27. D.F. Stroup, J.A. Berlin, and S.C. Morton et al. Meta-analysis Of Observational Studies in Epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) Group JAMA 283 15 2000 2008 2012
28. Adler A, Casula A, Steenkamp R, et al. Association between glycaemia and mortality in diabetic individuals on renal replacement therapy in the United Kingdom. Oral presentation at: American Diabetes Association Conference; June 8-12, 2012; Philadelphia, PA.
29. C. Drechsler, V. Krane, E. Ritz, W. Marz, and C. Wanner Glycemic control and cardiovascular events in diabetic hemodialysis patients Circulation 120 24 2009 2421 2428
30. B.I. Freedman, L. Andries, and Z.K. Shihabi et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients Clin J Am Soc Nephrol 6 7 2011 1635 1643
31. Y. Hayashino, S. Fukuhara, and T. Akiba et al. Diabetes, glycaemic control and mortality risk in patients on hemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study Diabetologia 50 6 2007 1170 1177
32. T. Okada, T. Nakao, and H. Matsumoto et al. Association between markers of glycemic control, cardiovascular complications and survival in type 2 diabetic patients with end-stage renal disease Intern Med 46 12 2007 807 814
33. T. Oomichi, M. Emoto, and T. Tabata et al. Impact of glycemic control on survival of diabetic patients on chronic regular nemodialysis - a 7-year observational study Diabetes Care 29 7 2006 1496 1500
34. J. Ricks, M.Z. Molnar, and C.P. Kovesdy et al. Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study Diabetes 61 3 2012 708 715
35. S. Shurraw, S.R. Majumdar, R. Thadhani, N. Wiebe, and M. Tonelli Glycemic control and the risk of death in 1,484 patients receiving maintenance hemodialysis Am J Kidney Dis 55 5 2010 875 884
36. 1c values with mortality and cardiovascular events in diabetic dialysis patients. The INVOR Study and review of the literature PLoS One 6 5 2011 e20093
37. M.E. Williams, E. Lacson Jr., W. Wang, J.M. Lazarus, and R. Hakim Glycemic control and extended hemodialysis survival in patients with diabetes mellitus: comparative results of traditional and time-dependent Cox model analyses Clin J Am Soc Nephrol 5 9 2010 1595 1601
38. 1c levels Diabetes Res Clin Pract 83 3 2009 320 326
39. K. Kalantar-Zadeh, J. Aronovitz, and J.D. Kopple et al. A1C and survival in maintenance hemodialysis patients Diabetes Care 30 5 2007 1049 1055
40. T. Morioka, M. Emoto, and T. Tabata et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis Diabetes Care 24 5 2001 909 913
41. K. Shima, M. Komatsu, K. Kawahara, J. Minaguchi, and S. Kawashima Stringent glycaemic control prolongs survival in diabetic patients with end-stage renal disease on hemodialysis Nephrology 15 6 2010 632 638
42. Y. Tsujimoto, E. Ishimura, and H. Tahara et al. Poor glycemic control is a significant predictor of cardiovascular events in chronic hemodialysis patient with diabetes Ther Apher Dial 13 4 2009 358 365
43. T. Okada, T. Nakao, and H. Matsumoto et al. Predialysis factors related to prognosis in type 2 diabetic patients on chronic dialysis in Japan Nephrology 7 2002 250 256
44. M.S. Wu, C.C. Yu, and C.W. Yang et al. Poor pre-dialysis glycaemic control is a predictor of mortality in type 2 diabetic patients on maintenance hemodialysis Nephrol Dial Transplant 12 1997 2105 2110
45. M.E. Williams, E. Lacson, M. Teng, N. Ofsthun, and J.M. Lazarus Hemodialyzed type I and type II diabetic patients in the US: characteristics, glycemic control, and survival Kidney Int 70 8 2006 1503 1509
46. M.K. Parmar, V. Torri, and L. Stewart Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints Stat Med 17 24 1998 2815 2834
47. I.H. de Boer, T.C. Rue, and P.A. Cleary et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort Arch Intern Med 171 5 2011 412 420
48. H.C. Gerstein, M.E. Miller, and R.P. Byington et al. Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 24 2008 2545 2559
49. E.S. Huang, J.Y. Liu, H.H. Moffet, P.M. John, and A.J. Karter Glycemic control, complications, and death in older diabetic patients: the Diabetes and Aging Study Diabetes Care 34 6 2011 1329 1336
50. K.K. Ray, S.R.K. Seshasai, and S. Wijesuriya et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials Lancet 373 9677 2009 1765 1772
51. S. Zoungas, J. Chalmers, and T. Ninomiya et al. Association of HbA(1c) levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds Diabetologia 55 3 2012 636 643
52. A. Patel, S. MacMahon, and J. Chalmers et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 24 2008 2560 2572
53. B.I. Freedman, R.N. Shenoy, and J.A. Planer et al. Comparison of glycated albumin and hemoglobin A(1c) concentrations in diabetic subjects on peritoneal and hemodialysis Perit Dial Int 30 1 2010 72 79
54. F. Vos, J.B. Schollum, and R.J. Walker Glycated albumin is the preferred marker for assessing glycaemic control in advanced chronic kidney disease Nephrol Dial Transplant Plus 4 2011 368 375
55. I.H. Khan, G.R. Catto, N. Edward, and A.M. MacLeod Death during the first 90 days of dialysis: a case control study Am J Kidney Dis 25 2 1995 276 280
56. J.M. Soucie, and W.M. McClellan Early death in dialysis patients: risk factors and impact on incidence and mortality rates J Am Soc Nephrol 7 10 1996 2169 2175
57. B.D. Bradbury, R.B. Fissell, and J.M. Albert et al. Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Clin J Am Soc Nephrol 2 1 2007 89 99
58. F.A. Gotch, and J.A. Sargent A mechanistic analysis of the National Cooperative Dialysis Study (NCDS) Kidney Int 28 3 1985 526 534
59. S.F. Leavey, R.L. Strawderman, C.A. Jones, F.K. Port, and P.J. Held Simple nutritional indicators as independent predictors of mortality in hemodialysis patients Am J Kidney Dis 31 6 1998 997 1006
60. B.A. Cooper, E.L. Penne, L.H. Bartlett, and C.A. Pollock Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD Am J Kidney Dis 43 1 2004 61 66